ApprovalTrail

Medical device licence · 62683 · Class 2

STELLANT SX INJECTOR SYSTEM

Yes: licensed in Canada

Licence status Issued (active); first licensed June 11, 2003. It is in Health Canada’s list of active licences.
Licence number
62683
Licence holder
Bayer Medical Care Inc. Also Doing Business As Medrad, Inc.Indianola, PA, United States
Risk class
Class II (low to moderate risk)
Licence type
System
First licensed
June 11, 2003
Devices covered
9

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • STELLANT CT INJECTOR SYSTEM - P3T CARDIACFLOW SOFTWARE UPGRADE
  • STELLANT SX INJECTOR SYSTEM - DISPLAY CONTROL CABLE
  • STELLANT SX INJECTOR SYSTEM - IMAGING SYSTEM INTERFACE
  • STELLANT SX INJECTOR SYSTEM - INJECTOR HEAD EXTENSION CABLES
  • STELLANT SX INJECTOR SYSTEM - P3T ABDOMEN SOFTWARE UPGRADE
  • STELLANT SX INJECTOR SYSTEM - P3T CARDIACFLOW SOFTWARE UPGRADE
  • STELLANT SX INJECTOR SYSTEM - P3T PULMONARY ANGIOGRAPHY SOFTWARE
  • STELLANT SX INJECTOR SYSTEM - REMOTE COILED STARTER SWITCH
  • STELLANT SX INJECTOR SYSTEM - SYRINGE HEATER

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “stellant”. A notice may cover another product or only some lots: read it to see what it covers.

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.